vs
Acadia Healthcare Company, Inc.（ACHC）与B&G Foods, Inc.（BGS）财务数据对比。点击上方公司名可切换其他公司
Acadia Healthcare Company, Inc.的季度营收约是B&G Foods, Inc.的1.9倍（$829.0M vs $439.3M），Acadia Healthcare Company, Inc.净利率更高（0.5% vs -4.4%，领先4.9%），Acadia Healthcare Company, Inc.同比增速更快（7.5% vs -4.7%），过去两年Acadia Healthcare Company, Inc.的营收复合增速更高（2.0% vs -12.8%）
阿卡迪亚医疗公司是美国的营利性行为医疗健康服务提供商，目前在美国及波多黎各地区运营着超过225家医疗机构，搭建了覆盖广泛的行为健康服务网络，为有相关需求的人群提供专业的心理健康与行为干预服务。
B&G Foods是总部位于美国新泽西州帕西帕尼的品牌食品控股企业，创立于1996年，成立初衷是收购1889年诞生于曼哈顿的酸黄瓜、调味酱及调味品生产商Bloch & Guggenheimer，如今在北美食品领域拥有众多知名品牌。
ACHC vs BGS — 直观对比
营收规模更大
ACHC
是对方的1.9倍
$439.3M
营收增速更快
ACHC
高出12.2%
-4.7%
净利率更高
ACHC
高出4.9%
-4.4%
两年增速更快
ACHC
近两年复合增速
-12.8%
损益表 — Q1 FY2026 vs Q3 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $829.0M | $439.3M |
| 净利润 | $4.5M | $-19.1M |
| 毛利率 | — | 22.5% |
| 营业利润率 | — | 2.5% |
| 净利率 | 0.5% | -4.4% |
| 营收同比 | 7.5% | -4.7% |
| 净利润同比 | -50.8% | -356.5% |
| 每股收益（稀释后） | $0.05 | $-0.24 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ACHCBGS
| Q1 26 | $829.0M | — | ||
| Q4 25 | $821.5M | — | ||
| Q3 25 | $851.6M | $439.3M | ||
| Q2 25 | $869.2M | $424.4M | ||
| Q1 25 | $770.5M | $425.4M | ||
| Q4 24 | $774.2M | $551.6M | ||
| Q3 24 | $815.6M | $461.1M | ||
| Q2 24 | $796.0M | $444.6M |
净利润ACHCBGS
| Q1 26 | $4.5M | — | ||
| Q4 25 | $-1.2B | — | ||
| Q3 25 | $36.2M | $-19.1M | ||
| Q2 25 | $30.1M | $-9.8M | ||
| Q1 25 | $8.4M | $835.0K | ||
| Q4 24 | $32.6M | $-222.4M | ||
| Q3 24 | $68.1M | $7.5M | ||
| Q2 24 | $78.5M | $3.9M |
毛利率ACHCBGS
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | 22.5% | ||
| Q2 25 | — | 20.5% | ||
| Q1 25 | — | 21.2% | ||
| Q4 24 | — | 21.5% | ||
| Q3 24 | — | 22.2% | ||
| Q2 24 | — | 20.7% |
营业利润率ACHCBGS
| Q1 26 | — | — | ||
| Q4 25 | -142.4% | — | ||
| Q3 25 | 4.7% | 2.5% | ||
| Q2 25 | 5.8% | 5.2% | ||
| Q1 25 | 1.7% | 8.4% | ||
| Q4 24 | 4.9% | -46.6% | ||
| Q3 24 | 12.1% | 11.1% | ||
| Q2 24 | 13.4% | 9.9% |
净利率ACHCBGS
| Q1 26 | 0.5% | — | ||
| Q4 25 | -143.3% | — | ||
| Q3 25 | 4.3% | -4.4% | ||
| Q2 25 | 3.5% | -2.3% | ||
| Q1 25 | 1.1% | 0.2% | ||
| Q4 24 | 4.2% | -40.3% | ||
| Q3 24 | 8.4% | 1.6% | ||
| Q2 24 | 9.9% | 0.9% |
每股收益（稀释后）ACHCBGS
| Q1 26 | $0.05 | — | ||
| Q4 25 | $-12.98 | — | ||
| Q3 25 | $0.40 | $-0.24 | ||
| Q2 25 | $0.33 | $-0.12 | ||
| Q1 25 | $0.09 | $0.01 | ||
| Q4 24 | $0.36 | $-2.81 | ||
| Q3 24 | $0.74 | $0.09 | ||
| Q2 24 | $0.85 | $0.05 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $158.5M | $60.9M |
| 总债务越低越好 | $2.5B | $2.0B |
| 股东权益账面价值 | $2.0B | $470.7M |
| 总资产 | $5.5B | $2.9B |
| 负债/权益比越低杠杆越低 | 1.29× | 4.30× |
8季度趋势，按日历期对齐
现金及短期投资ACHCBGS
| Q1 26 | $158.5M | — | ||
| Q4 25 | $133.2M | — | ||
| Q3 25 | $118.7M | $60.9M | ||
| Q2 25 | $131.4M | $54.1M | ||
| Q1 25 | $91.2M | $61.2M | ||
| Q4 24 | $76.3M | $50.6M | ||
| Q3 24 | $82.1M | $54.7M | ||
| Q2 24 | $77.2M | $40.3M |
总债务ACHCBGS
| Q1 26 | $2.5B | — | ||
| Q4 25 | $2.5B | — | ||
| Q3 25 | $2.3B | $2.0B | ||
| Q2 25 | $2.3B | $2.0B | ||
| Q1 25 | $2.2B | $2.0B | ||
| Q4 24 | $2.0B | $2.0B | ||
| Q3 24 | $1.9B | $2.1B | ||
| Q2 24 | $1.8B | $2.0B |
股东权益ACHCBGS
| Q1 26 | $2.0B | — | ||
| Q4 25 | $1.9B | — | ||
| Q3 25 | $3.1B | $470.7M | ||
| Q2 25 | $3.1B | $501.4M | ||
| Q1 25 | $3.0B | $513.1M | ||
| Q4 24 | $3.1B | $524.8M | ||
| Q3 24 | $3.0B | $755.3M | ||
| Q2 24 | $3.0B | $765.0M |
总资产ACHCBGS
| Q1 26 | $5.5B | — | ||
| Q4 25 | $5.5B | — | ||
| Q3 25 | $6.4B | $2.9B | ||
| Q2 25 | $6.3B | $2.9B | ||
| Q1 25 | $6.1B | $3.0B | ||
| Q4 24 | $6.0B | $3.0B | ||
| Q3 24 | $5.9B | $3.4B | ||
| Q2 24 | $5.7B | $3.4B |
负债/权益比ACHCBGS
| Q1 26 | 1.29× | — | ||
| Q4 25 | 1.28× | — | ||
| Q3 25 | 0.74× | 4.30× | ||
| Q2 25 | 0.74× | 3.97× | ||
| Q1 25 | 0.72× | 3.91× | ||
| Q4 24 | 0.64× | 3.85× | ||
| Q3 24 | 0.62× | 2.75× | ||
| Q2 24 | 0.62× | 2.67× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $61.5M | $-64.6M |
| 自由现金流经营现金流 - 资本支出 | — | $-70.7M |
| 自由现金流率自由现金流/营收 | — | -16.1% |
| 资本支出强度资本支出/营收 | — | 1.4% |
| 现金转化率经营现金流/净利润 | 13.78× | — |
| 过去12个月自由现金流最近4个季度 | — | $54.8M |
8季度趋势，按日历期对齐
经营现金流ACHCBGS
| Q1 26 | $61.5M | — | ||
| Q4 25 | $-86.3M | — | ||
| Q3 25 | $73.2M | $-64.6M | ||
| Q2 25 | $133.5M | $17.8M | ||
| Q1 25 | $11.5M | $52.7M | ||
| Q4 24 | $116.7M | $80.3M | ||
| Q3 24 | $163.1M | $4.2M | ||
| Q2 24 | $171.1M | $11.3M |
自由现金流ACHCBGS
| Q1 26 | — | — | ||
| Q4 25 | $-179.5M | — | ||
| Q3 25 | $-63.0M | $-70.7M | ||
| Q2 25 | $-34.2M | $11.5M | ||
| Q1 25 | $-163.2M | $42.4M | ||
| Q4 24 | $-86.8M | $71.7M | ||
| Q3 24 | $-27.1M | $-679.0K | ||
| Q2 24 | $16.9M | $5.2M |
自由现金流率ACHCBGS
| Q1 26 | — | — | ||
| Q4 25 | -21.8% | — | ||
| Q3 25 | -7.4% | -16.1% | ||
| Q2 25 | -3.9% | 2.7% | ||
| Q1 25 | -21.2% | 10.0% | ||
| Q4 24 | -11.2% | 13.0% | ||
| Q3 24 | -3.3% | -0.1% | ||
| Q2 24 | 2.1% | 1.2% |
资本支出强度ACHCBGS
| Q1 26 | — | — | ||
| Q4 25 | 11.3% | — | ||
| Q3 25 | 16.0% | 1.4% | ||
| Q2 25 | 19.3% | 1.5% | ||
| Q1 25 | 22.7% | 2.4% | ||
| Q4 24 | 26.3% | 1.6% | ||
| Q3 24 | 23.3% | 1.0% | ||
| Q2 24 | 19.4% | 1.4% |
现金转化率ACHCBGS
| Q1 26 | 13.78× | — | ||
| Q4 25 | — | — | ||
| Q3 25 | 2.02× | — | ||
| Q2 25 | 4.43× | — | ||
| Q1 25 | 1.37× | 63.17× | ||
| Q4 24 | 3.58× | — | ||
| Q3 24 | 2.39× | 0.56× | ||
| Q2 24 | 2.18× | 2.87× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ACHC
| Acute Inpatient Psychiatric Facilities | $471.0M | 57% |
| Other | $140.0M | 17% |
| Specialty Treatment Facilities | $128.0M | 15% |
| Residential Treatment Facilities | $90.0M | 11% |
BGS
| Specialty Segment | $150.5M | 34% |
| Meals Segment | $110.0M | 25% |
| Spices And Flavor Solutions Segment | $101.4M | 23% |
| Frozen And Vegetables Segment | $77.4M | 18% |
